EUVIMEDEUVIMED entdecken
Open Access

Anticoagulation Outcomes in Nursing Home Residents With Atrial Fibrillation and ADL Disability

Qiaoxi Chen, Daniel Singer, Chun-Ting Yang, Kevin T Pritchard, Dae Hyun Kim, Kueiyu Joshua Lin

JAMA Network Open · 2026

DOI: 10.1001/jamanetworkopen.2026.37533 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Network Open, 2026. Verfasst von Qiaoxi Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massach…. Hauptthemen laut MEDLINE: Atrial Fibrillation, Anticoagulants, Activities of Daily Living. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Long-term nursing home residents with atrial fibrillation (AF) and activities of daily living (ADL) disability are at high risk of bleeding and death, making the net benefit of anticoagulation uncertain.

Objective

To compare the association of oral anticoagulant (OAC) use vs nonuse with ischemic stroke and major bleeding in long-term nursing home residents with AF and ADL disability. Design, Setting, and Participants This cohort study used US Medicare claims linked with the Minimum Data Set (January 1, 2013, to December 31, 2022). Nursing home residents with nonvalvular AF and impairment in 3 or more ADLs were included. Three cohorts comparing use of apixaban, rivaroxaban, or warfarin with nonuse were constructed using incidence-density sampling. Exposures Initiation of apixaban, rivaroxaban, or warfarin use. Main Outcomes and Measures Primary outcomes were ischemic stroke, major bleeding, and their composite. Propensity score (PS) matching balanced 111 covariates. Adjusted rate ratios (ARRs) with 95% CIs were estimated. Tipping-point analyses assessed the relative weighting ischemic stroke vs major bleeding required to favor anticoagulation. Direct active-comparator analyses compared apixaban with rivaroxaban and warfarin.

Results

The study comprised 26 940 nursing home residents (median [IQR] age, 82 [74,88] years; 17 504 [65.0%] female), including PS-matched cohorts of 7600 residents receiving apixaban, 2654 receiving rivaroxaban, and 3216 receiving warfarin. Compared with nonuse, use of all OACs was associated with lower rates of ischemic stroke (apixaban: ARR, 0.53; 95% CI, 0.38-0.73; rivaroxaban: ARR, 0.48; 95% CI, 0.27-0.87; warfarin: ARR, 0.47; 95% CI, 0.25-0.88) and higher rates of major bleeding (apixaban: ARR, 1.62; 95% CI, 1.29-2.03; rivaroxaban: ARR, 2.68; 95% CI, 1.84-3.93; warfarin: ARR, 3.02; 95% CI, 2.15-4.25). Only apixaban was not associated with a higher composite outcome (ARR, 1.08; 95% CI, 0.90-1.30), whereas rivaroxaban (ARR, 1.62; 95% CI, 1.20-2.18) and warfarin (ARR, 1.99; 95% CI, 1.50-2.63) were associated with higher rates. Findings were consistent across frailty strata, although stroke reduction with apixaban was attenuated among frail individuals. Tipping-point analyses indicated a more favorable benefit-risk balance for apixaban than for rivaroxaban or warfarin. Conclusions and Relevance Among nursing home residents with AF and ADL disability, OAC use was associated with lower ischemic stroke but higher major bleeding rates than nonuse. Apixaban demonstrated the most favorable benefit-risk profile among the OACs evaluated. These findings may inform individualized anticoagulation decisions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationAnticoagulantsActivities of Daily LivingHumansFemaleNursing Home ResidentsMaleAgedAged, 80 and overUnited StatesNursing HomesHemorrhagePyrazolesCohort StudiesPyridonesWarfarinRivaroxabanMedicareStrokePersons with Disabilities

Substanzen

AnticoagulantsPyrazolesPyridonesWarfarinapixabanRivaroxaban

Autor:innen und Institutionen

  • Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Division of General Internal Medicine, Department of Medicine, Massachusetts General Hospital, Boston.
  • Department of Medicine, Harvard Medical School, Boston, Massachusetts.
  • The Hinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife, Harvard Medical School, Boston, Massachusetts.

Zitieren

APA

Chen, Q., Singer, D., Yang, C. T., Pritchard, K. T., Kim, D. H., & Lin, K. J. (2026). Anticoagulation Outcomes in Nursing Home Residents With Atrial Fibrillation and ADL Disability. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2026.37533

Vancouver

Chen Q, Singer D, Yang CT, Pritchard KT, Kim DH, Lin KJ. Anticoagulation Outcomes in Nursing Home Residents With Atrial Fibrillation and ADL Disability. JAMA Network Open. 2026. doi:10.1001/jamanetworkopen.2026.37533

BibTeX
@article{Chen2026,
  author = {Chen, Qiaoxi and Singer, Daniel and Yang, Chun-Ting and Pritchard, Kevin T and Kim, Dae Hyun and Lin, Kueiyu Joshua},
  title = {Anticoagulation Outcomes in Nursing Home Residents With Atrial Fibrillation and ADL Disability},
  journal = {JAMA Network Open},
  year = {2026},
  doi = {10.1001/jamanetworkopen.2026.37533}
}
Kostenlos starten →